Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Change in Account Payables (2016 - 2026)

Tandem Diabetes Care filings provide 11 years of Change in Account Payables readings, the most recent being $5.8 million for Q4 2025.

  • On a quarterly basis, Change in Account Payables rose 504.03% to $5.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.2 million, a 193.1% increase, with the full-year FY2025 number at $2.2 million, up 193.1% from a year prior.
  • Change in Account Payables hit $5.8 million in Q4 2025 for Tandem Diabetes Care, up from -$9.3 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $10.5 million in Q1 2021 to a low of -$9.3 million in Q3 2025.
  • Median Change in Account Payables over the past 3 years was -$898000.0 (2025), compared with a mean of $1.2 million.
  • The widest YoY moves for Change in Account Payables: up 504.03% in 2025, down 682.06% in 2025.
  • Tandem Diabetes Care's Change in Account Payables stood at $10.5 million in 2021, then plummeted by 113.67% to -$1.4 million in 2024, then soared by 504.03% to $5.8 million in 2025.
  • The last three reported values for Change in Account Payables were $5.8 million (Q4 2025), -$9.3 million (Q3 2025), and -$898000.0 (Q2 2025) per Business Quant data.